Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

NCT00136565 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG: Velcade
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Cyclophosphamide
DRUG: Vindesine
DRUG: Bleomycin

Sponsor

Lymphoma Study Association

Collaborators

[object Object]